Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yindan Xintai Dropping Pill is a traditional Chinese medicine (TCM) formulation used primarily for the treatment of angina pectoris caused by coronary heart disease. It is administered in the form of "dropping pills," a common TCM dosage form designed for rapid absorption. The product combines multiple herbal ingredients, with its mechanism believed to involve anti-atherosclerotic and cardioprotective effects, such as improving blood circulation and reducing symptoms associated with coronary artery disease. Its use has been evaluated in cost-benefit analyses for angina pectoris management[1]. The precise pharmacological targets are not fully elucidated but are thought to include modulation of lipid metabolism, improvement of endothelial function, and reduction of myocardial ischemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yindan Xintai Dropping Pill.